Autologous Cell Therapies for Cerebral Palsy-Chronic (ACT for CP) Individual Patient Expanded Access IND Protocol
| Registry | NCT03203941 |
|---|---|
| Status | No longer available |
| Study type | Expanded access |
| Sponsor | Charles Cox (Other) |
| Conditions | Cerebral Palsy |
| Interventions | Autologous Cord Blood Stem Cells (Biological) |
| Dates | first posted 2017-06-29, last updated 2020-05-13 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Cerebral Palsy All trials of Autologous Cord Blood Stem Cells
Individual patient expanded access protocol for a child with cerebral palsy (CP) who has autologous umbilical cord blood available and who is ineligible to participate in other stem cell studies for children with CP.
This protocol is part of an FDA Individual Patient Expanded Access IND submitted at the request of the parents of a child with cerebral palsy (CP) who is ineligible to participate in other stem cell studies. For this child, there are no other treatment options.
Inclusion Criteria: \- Exclusion Criteria: \-
| Facility | City | Country | Status |
|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston, Texas | United States |